13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Page 7 of 9 – SEC Filing

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and correct.

March 15, 2018
(Date)
BROADFIN CAPITAL, LLC
By:  /s/ Kevin Kotler
Kevin Kotler, Managing Member
KEVIN KOTLER
/s/ Kevin Kotler
BROADFIN HEALTHCARE MASTER FUND, LTD.
By:  /s/ Kevin Kotler
Kevin Kotler, Director

Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (see 18 U.S.C. 1001).

Follow Societal Cdmo Inc. (NASDAQ:SCTL)